Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Avandia on Cognition and Cerebral Glucose Utilisation in Subjects With Mild to Moderate Alzheimer's Disease (AD).

NCT00265148 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00265148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00265148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Avandia on Cognition and Cerebral Glucose Utilisation in Subjects With Mild to Moderate Alzheimer's Disease (AD).
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
May 18, 2004
Completion date
July 10, 2008
Enrollment
80 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease